Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-α in cultured human synovial cells

Journal of Rheumatology

Volumn 24, Issue 9, 1997, Pages 1680-1684

  Sato, Motoyoshi ^a   Miyazaki, Takashi ^a   Kambe, Fukushi ^a   Maeda, Kenji ^b   Seo, Hisao ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Chemotactic cytokines; Factor alpha; Nuclear factor kappa B; Quercetin; Rheumatoid arthritis; Synovial cells; Tumor necrosis

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; QUERCETIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; GENE REPRESSION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN INDUCTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

ARTHRITIS, RHEUMATOID; BLOTTING, NORTHERN; CELLS, CULTURED; CHEMOKINE CCL2; DNA PROBES; HUMANS; HYDROGEN PEROXIDE; INTERLEUKIN-8; NF-KAPPA B; QUERCETIN; RECOMBINANT PROTEINS; RNA, MESSENGER; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030867845     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Harris EJ: Rheumatoid arthritis: Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
2. Brennan FM, Field M, Chu CQ, Feldmann M, Maini RN: Cytokine expression in rheumatoid arthritis. Br J Rheumatol 1991;(suppl 1)30:76-80.
3. Bedard PA, Golds EE: Cytokine-induced expression of mRNAs for chemotactic factors in human synovial cells and fibroblasts. J Cell Physiol 1993;154:433-41.
4. Baeuerle PA, Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994;12:141-79.
5. Miyamoto S, Verma I: Rel/NF-κB/IκB story. Adv Cancer Res 1995;66:255-92.
6. Kopp EB, Gosh S: NF-κB and rel proteins in innate immunity. Adv Immunol 1995;58:1-27.
7. Sato M, Miyazaki T, Nagaya T, et al: Antioxidants inhibit tumor necrosis factor-α mediated stimulation of interleukin-8, monocyte chemoattractant protein-1 and collagenase expression in cultured human synovial cells. J Rheumatol 1996;23:432-8.
8. Harborne JB: The Flavonoids. Advance in Research since 1980. London: Chapman & Hall, 1988.
9. Gabor M: Anti-inflammatory and anti-allergic properties of flavonoids. Prog Clin Biol Res 1986;213:471-80.
10. Vrijsen R, Everaert L, Boeye A: Antiviral activity of flavones and potentiation by ascorbate. J Gen Virol 1988;69:1749-51.
11. Brown JP: A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds. Mutation Res 1980;75:243-77.
12. Bors W, Heller W, Michel C, Saran M: Flavonoids as antioxidants: Determination of radical-scavenging efficiencies. Methods Enzymol 1990;186:343-55.
13. Kantengwa S, Polla BS: Flavonoids, but not protein kinase C inhibitors, prevent stress protein synthesis during erythrophagocytosis. Biochem Biophys Res Commun 1991;180:308-14.
14. Miyazaki T, Sato M, Murata Y, Maeda K, Seo H: Factor(s) present in serum from patients on long-term hemodialysis increase(s) mRNAs for collagenase and stromelysin in synovial cells. Am J Nephrol 1995;15:48-56.
15. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
16. Kambe F, Seo H, Murata Y, Matsui N: Cloning of a complementary deoxyribonucleic acid coding for human thyroxine-binding globulin (TBG): Existence of two TBG messenger ribonucleic acid species processing different 3′-untranslated regions. Mol Endocrinol 1988;2:181-5.
17. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principal of protein-dye binding. Anal Biochem 1976;72:248-54.
18. Stein B, Baldwin AJ: Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-κB. Mol Cell Biol 1993;13:7191-8.
19. Mukaida N, Mahe Y, Matsushima K: Cooperative interaction of nuclear factor-κB-and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem 1990;265:21128-33.
20. Shyy YJ, Li YS, Kolattukudy PE: Structure of human monocyte chemotactic protein gene and its regulation by TPA. Biochem Biophys Res Commun 1990;169:346-51.
21. Gerritsen ME, Carley WW, Ranges GE, et al: Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am J Pathol 1995;147:278-92.
22. Wei H, Bowen R, Cai Q, Barnes S, Wang Y: Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 1995;208:124-30.
23. Yang Z, Costanzo M, Golde DW, Kolesnick RN: Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor κB translocation in intact HL-60 cells. J Biol Chem 1993;268:20520-3.
24. Westwick JK, Bielawska AE, Dbaibo G, Hannun YA, Brenner DA: Ceramide activates the stress-activated protein kinases. J Biol Chem 1995;270:22689-92.
25. Schutze S, Machleidt T, Kronke M: Mechanism of tumor necrosis factor action. Semin Oncol 1995;(suppl 4)19:16-24.
26. Schreck R, Rieber P, Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991;10:2247-58.
27. Feng L, Xia Y, Garcia GE, Hwang D, Wilson CB: Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α, and lipopolysaccharide. J Clin Invest 1995;95:1669-75.
28. Goossens V, Grooten J, De Vos K, Fiers W: Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc Natl Acad Sci USA 1995;92:8115-9.
29. Read MA, Neish AS, Luscinskas FW, Palombella VJT, Maniatis T, Collins T: The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity 1995;2:493-506.
30. Enari M, Hug H, Nagata S: Involvement of an ICE-like proteinase in Fas-mediated apoptosis. Nature 1995;375:78-81.
31. Voelkel-Johnson C, Entingh AJ, Wold WS, Gooding LR, Laster SM: Activation of intracellular proteases is an early event in TNF-induced apoptosis. J Immunol 1995;154:1707-16.
32. Traenckner EB, Wilk S, Baeuerle PA: A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J 1994;13:5433-41.
33. Mellits KH, Hay RT, Goodbourn S: Proteolytic degradation of MAD3 (IκBα) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of NF-κB. Nucleic Acids Res 1993;21:5059-66.
34. Gschwendt M, Horn F, Kittstein W, Marks F: Inhibition of the calcium-and phospholipid-dependent protein kinase activity from mouse brain cytosol by quercetin. Biochem Biophys Res Commun 1983;117:444-7.
35. Gschwendt M, Horn F, Kittstein W, Furstenberger G, Besemfelder E, Marks F: Calcium and phospholipid-dependent protein kinase activity in mouse epidermis cytosol: Stimulation by complete and incomplete tumor promoters and inhibition by various compounds. Biochem Biophys Res Commun 1984;124:63-8.
36. Cunningham BD, Threadgill MD, Groundwater PW, Dale IL, Hickman JA: Synthesis and biological evaluation of a series of flavones designed as inhibitors of protein tyrosine kinases. Anticancer Drug Des 1992;7:365-84.